Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

Metabolite Isotopomer Ratio Measurement: Principles, Analytical Methods, and Applications

Metabolite isotopomer ratio measurement is a cornerstone technique of stable isotope-resolved metabolomics that quantifies how labeled atoms from tracers such as 13C-glucose or 13C-glutamine distribute across intracellular metabolites, providing direct readouts of pathway activity and metabolic flux. By coupling isotope tracing with LC-MS/MS, GC-MS, high-resolution mass spectrometry, and NMR, this approach resolves metabolic rewiring in cancer cells, microbes, plants, and clinical specimens with quantitative precision. This article introduces the technical principles, sample requirements, testing items, analytical workflows, and typical applications of metabolite isotopomer ratio determination.

Technical Overview

Metabolite isotopomer ratio measurement, also known as mass isotopomer distribution analysis (MIDA) or isotopologue profiling, quantifies the relative abundances of metabolite species that differ only in their isotopic composition. In a typical experiment, a biological system is supplied with a stable isotope-labeled nutrient, most commonly uniformly 13C-labeled glucose ([U-13C6]glucose) or glutamine ([U-13C5,15N2]glutamine), and the label is incorporated into downstream metabolites through enzymatic reactions. Mass spectrometry then resolves each metabolite into its isotopologue series (M+0, M+1, M+2, through M+n), while NMR can further distinguish positional isotopomers, in which the labeled atoms occupy defined molecular positions.

Because metabolite pool sizes alone cannot distinguish flux through parallel pathways, isotopomer ratios provide the discriminating information. For example, after [U-13C6]glucose labeling, an elevated M+3 fraction of lactate reflects glycolytic carbon input, whereas citrate M+2 and M+5 fractions separate pyruvate dehydrogenase-mediated oxidative entry into the TCA cycle from glutamine-driven reductive carboxylation. Quantitative interpretation requires rigorous correction for natural isotope abundance, tracer isotopic purity, and adduct formation, followed by calculation of metrics such as fractional enrichment, isotopomer ratios, and, when combined with computational modeling, absolute metabolic fluxes.

Testing Samples

Cultured Cells

Adherent and suspension cell lines are the most common matrices. Typical protocols call for 1 to 5 million cells per condition (approximately 30 to 100 micrograms of total protein) with at least three to six biological replicates. Cells are cultured in tracer-supplemented medium for a defined window, often ranging from 5 minutes to 24 hours depending on pathway turnover, then rapidly quenched with pre-chilled 80% methanol to arrest metabolism within seconds. Direct scraping into cold extraction solvent and washing with ice-cold saline rather than PBS help preserve labile isotopomer distributions and minimize phosphate adducts.

Tissue Specimens

Fresh-frozen tissue from animal models, xenografts, organoids, or clinical biopsies (20 to 100 mg) can be analyzed. Tissues must be snap-frozen in liquid nitrogen or clamp-frozen under anesthesia to prevent post-excision metabolic turnover, which rapidly distorts isotopomer ratios. Homogenization is performed under cryogenic conditions in cold methanol, acetonitrile, and water mixtures, followed by centrifugation and optional solid-phase cleanup.

Biofluids

Plasma, serum, urine, cerebrospinal fluid, and culture medium (50 to 200 microliters) are suitable for tracing secreted metabolites such as lactate, alanine, glutamine, and citrate, as well as for in vivo tracer studies. Proteins are removed by cold acetonitrile or methanol precipitation, and results are normalized to sample volume, creatinine, or isotope-dilution internal standards.

Microbial and Fermentation Cultures

Bacteria, yeast, and filamentous fungi are central subjects of 13C metabolic flux analysis. Fast filtration with immediate transfer into cold solvent, or direct quenching of culture aliquots, captures intracellular isotopomer patterns. Extracellular labeling of residual substrate, biomass hydrolysates (proteinogenic amino acids), and secreted products are frequently measured together to constrain flux solutions.

Plant and Algal Samples

Leaf discs, seeds, roots, and algal pellets (50 to 200 mg fresh weight) support studies of photosynthetic carbon fixation, photorespiration, and nitrogen assimilation using 13CO2 or 15N-nitrate tracers. Quenching in liquid nitrogen followed by methanol, chloroform, and water extraction preserves both polar and lipid fractions for biphasic isotopomer analysis.

Testing Items

The service portfolio covers the major pools of central carbon and nitrogen metabolism, with each metabolite quantified across its full isotopologue envelope:

  • Glycolysis and gluconeogenesis intermediates: glucose-6-phosphate, fructose-6-phosphate, fructose-1,6-bisphosphate, 3-phosphoglycerate, phosphoenolpyruvate, pyruvate, and lactate.
  • Pentose phosphate pathway metabolites: 6-phosphogluconate, ribose-5-phosphate, sedoheptulose-7-phosphate, and erythrose-4-phosphate.
  • TCA cycle intermediates: citrate, cis-aconitate, isocitrate, alpha-ketoglutarate, succinate, fumarate, and malate, including the diagnostically important citrate M+2 versus M+5 and succinate M+3 versus M+4 patterns.
  • Amino acids: alanine, serine, glycine, cysteine, aspartate, asparagine, glutamate, glutamine, proline, arginine, and branched-chain amino acids, with 15N and 13C labeling resolved in parallel.
  • Nucleotides, nucleotide sugars, and one-carbon donors: ATP, GTP, UTP, CTP, NAD and NADH, and S-adenosylmethionine, enabling assessment of de novo synthesis versus salvage contributions.
  • Lipids and fatty acids: palmitate (M+0 through M+16), stearate, oleate, and phospholipid acyl chains for de novo lipogenesis and desaturation analysis, including positional isotopomer information via MS/MS or NMR.
  • Supported tracers: [U-13C6]glucose, [1-13C]glucose, [1,2-13C2]glucose, [U-13C5]glutamine, [U-13C5,15N2]glutamine, [5-13C]glutamine, [U-13C2]acetate, 13C-palmitate, 15NH4Cl, 15N-amino acids, and deuterated water.

Testing Methods

Sample Preparation and Quenching

All workflows begin with metabolism-arresting extraction. Cold 80% methanol, methanol, acetonitrile, and water (2:2:1) mixtures, or methanol and chloroform biphasic systems are used together with isotopically matched or non-natural internal standards. Extracts are dried under nitrogen or lyophilized, reconstituted in chromatographic starting conditions, and maintained at 4 degrees Celsius in the autosampler to minimize isotope exchange and degradation.

Targeted LC-MS/MS

Triple-quadrupole LC-MS/MS operated in multiple reaction monitoring (MRM) is the workhorse platform for quantifying isotopologue distributions of predefined metabolites. Hydrophilic interaction chromatography (HILIC) with volatile ammonium formate or acetate buffers separates polar metabolites, while reverse-phase columns handle lipids. Dedicated MRM transitions are acquired for every isotopologue, with retention-time alignment and peak-area integration verified against authentic standards. Linearity with R-squared values above 0.99, intra-day precision below 15% coefficient of variation, and low-picomolar detection limits are routinely achieved.

GC-MS Analysis

Gas chromatography-mass spectrometry after derivatization with MSTFA (trimethylsilyl esters) or MTBSTFA (tert-butyldimethylsilyl derivatives) provides robust quantification of organic acids, amino acids, and sugar phosphates. Electron-impact fragmentation yields diagnostic fragment ions that carry positional isotopomer information covering specific carbon positions of metabolites such as glutamate or serine, making GC-MS particularly valuable for generating constraints in 13C metabolic flux analysis.

High-Resolution Mass Spectrometry

Orbitrap and Q-TOF platforms operating at resolving powers above 60,000 with sub-5 ppm mass accuracy distinguish true 13C isotopologues from near-isobaric interferences and adducts. Full-scan acquisition also enables untargeted isotopologue discovery, in which newly labeled features are identified by their characteristic time-dependent mass shifts and expanding isotope envelopes.

NMR Spectroscopy

13C and 1H-13C HSQC NMR uniquely resolves positional isotopomers without authentic standards, because the chemical shift directly reports the labeled carbon position. This capability is essential for distinguishing, for example, [4,5-13C2]glutamate from [2,3-13C2]glutamate, whose mass spectrometric signatures are identical. Cryoprobe-equipped spectrometers achieve sufficient sensitivity for 10 to 50 mg of tissue or several million cells.

Data Correction, Quality Control, and Reporting

Raw isotopologue intensities are corrected for natural isotope abundance, tracer chemical purity, and isotopic interference using validated tools such as IsoCor, AccuCor, IsoCorrectoR, or in-house pipelines. Unlabeled control samples confirm correction accuracy, while isotope-dilution internal standards track instrument drift. Final reports include extracted ion chromatograms, corrected isotopologue fractions, fractional enrichment values, key isotopomer ratios (for example, citrate M+5 to M+2 or lactate M+3 to M+0), and optional flux modeling performed with frameworks such as INCA, 13CFLUX2, or OpenFlux.

Applications

  • Cancer metabolism research: quantifying Warburg-type glycolysis, glutamine anaplerosis, reductive carboxylation in hypoxic or IDH-mutant tumors, and de novo lipogenesis to expose metabolic vulnerabilities.
  • Drug mechanism of action and target engagement: demonstrating on-target inhibition of glycolytic, glutaminase, IDH, or fatty acid synthesis inhibitors through predictable shifts in isotopomer ratios.
  • 13C metabolic flux analysis in microbes: constraining genome-scale and core network models for strain engineering of amino acid, organic acid, and biofuel production hosts.
  • Immunometabolism: tracking glucose and glutamine utilization during T cell activation, macrophage polarization, and checkpoint inhibitor responses.
  • Plant and algal physiology: resolving photosynthetic carbon fixation, photorespiratory flux, C4 and CAM partitioning, and nitrogen assimilation under stress or engineered traits.
  • Clinical and translational studies: in vivo tracer protocols assessing hepatic gluconeogenesis, citrate cycling, and mitochondrial dysfunction, alongside stable isotope breath tests and inborn-error diagnostics.
  • Food authenticity and environmental forensics: compound-specific isotope ratios of metabolites verifying geographic origin, adulteration, and biosynthetic provenance.

FAQ

What is the difference between an isotopologue and an isotopomer?

An isotopologue is a molecular species differing only in the number of heavy isotope substitutions, such as lactate containing zero, one, two, or three 13C atoms. A positional isotopomer specifies which particular atoms are labeled, for example [2-13C]lactate versus [3-13C]lactate. Mass spectrometry natively quantifies isotopologues, while MS/MS fragmentation or NMR is required to resolve positional isotopomers.

How are natural isotope contributions corrected?

Every element contributes naturally occurring heavy isotopes that inflate higher mass channels. Correction algorithms convolve the theoretical isotope distribution of each molecular formula, including derivatization groups and common adducts, with the measured tracer purity, then solve for the true label incorporation. Correctness is verified with unlabeled samples, which should yield an isotopologue distribution matching theoretical natural abundance.

How much sample is needed and what labeling times are recommended?

As little as one million cultured cells, 20 mg of tissue, or 50 microliters of biofluid typically suffices for targeted panels. Labeling duration depends on pool turnover: minutes for glycolytic intermediates, one to several hours for TCA cycle intermediates and amino acids, and up to 24 to 48 hours for lipids and nucleotides. Time-course sampling at two to four points is recommended when isotopic steady state is uncertain.

Can isotopomer ratios be converted into absolute fluxes?

Yes. When corrected isotopomer fractions are combined with extracellular uptake and secretion rates and growth data, 13C-MFA frameworks estimate intracellular fluxes with statistical confidence intervals. Isotopically non-stationary MFA further exploits transient labeling kinetics for systems that do not reach isotopic steady state, such as mammalian cells with large metabolite pools.

What quality controls accompany the analysis?

Each batch includes unlabeled matrix controls, isotope-labeled internal standards, pooled quality-control injections, and standard reference materials to monitor retention time, mass accuracy, signal linearity, and correction validity. Only data passing predefined acceptance criteria, such as coefficient of variation below 15% and mass error below 5 ppm, are reported.

Why Choose ZKGX?

  • State-of-the-art analytical equipment
  • Highly qualified scientific team
  • Fast turnaround time
  • Competitive pricing